|Heart disease and stroke statistics—2015 update: a report from the American Heart Association|
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 131 (4), e29-e322, 2015
|Heart disease and stroke statistics—2017 update: a report from the American Heart Association|
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
|Heart disease and stroke statistics-2003 update|
American Heart Association
http://www. americanheart. org/downloadable/heart …, 2002
|Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men|
PM Ridker, M Cushman, MJ Stampfer, RP Tracy, CH Hennekens
New England journal of medicine 336 (14), 973-979, 1997
|Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid …|
CD Furberg, JT Wright, BR Davis, JA Cutler, M Alderman, H Black, ...
Journal of the American Medical Association 288 (23), 2981-2997, 2002
|Long-term effects of pravastatin on plasma concentration of C-reactive protein|
PM Ridker, N Rifai, MA Pfeffer, F Sacks, E Braunwald
Circulation 100 (3), 230-235, 1999
|Estrogen plus progestin and the risk of coronary heart disease|
JAE Manson, J Hsia, KC Johnson, JE Rossouw, AR Assaf, NL Lasser, ...
New England Journal of Medicine 349 (6), 523-534, 2003
|C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis|
Emerging Risk Factors Collaboration
The Lancet 375 (9709), 132-140, 2010
|Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis|
Ankle Brachial Index Collaboration
JAMA: the journal of the American Medical Association 300 (2), 197, 2008
|Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the …|
MR Jaff, MS McMurtry, SL Archer, M Cushman, N Goldenberg, ...
Circulation 123 (16), 1788-1830, 2011
|Incidence of and risk factors for atrial fibrillation in older adults|
BM Psaty, TA Manolio, LH Kuller, RA Kronmal, M Cushman, LP Fried, ...
Circulation 96 (7), 2455-2461, 1997
|Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association|
JC Hemphill III, SM Greenberg, CS Anderson, K Becker, BR Bendok, ...
Stroke 46 (7), 2032-2060, 2015
|Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association|
G Saposnik, F Barinagarrementeria, RD Brown Jr, CD Bushnell, ...
Stroke 42 (4), 1158-1192, 2011
|Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines|
SR Kahn, W Lim, AS Dunn, M Cushman, F Dentali, EA Akl, DJ Cook, ...
Chest 141 (2), e195S-e226S, 2012
|Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.|
J Danesh, S Lewington, SG Thompson, G Lowe, R Collins, JB Kostis, ...
Jama 294 (14), 1799-1809, 2005
|COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review|
B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ...
Journal of the American college of cardiology 75 (23), 2950-2973, 2020
|The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study|
JI Barzilay, L Abraham, SR Heckbert, M Cushman, LH Kuller, HE Resnick, ...
Diabetes 50 (10), 2384-2389, 2001
|Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project|
RP Tracy, RN Lemaitre, BM Psaty, DG Ives, RW Evans, M Cushman, ...
Arteriosclerosis, thrombosis, and vascular biology 17 (6), 1121-1127, 1997
|Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism|
PM Ridker, SZ Goldhaber, E Danielson, Y Rosenberg, CS Eby, ...
New England Journal of Medicine 348 (15), 1425-1434, 2003
|Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study|
AB Newman, L Shemanski, TA Manolio, M Cushman, M Mittelmark, ...
Arteriosclerosis, thrombosis, and vascular biology 19 (3), 538-545, 1999